Treatment FailurePatient PreferencePatient SatisfactionTreatment OutcomeHeart FailureSensitivity and SpecificityRetrospective StudiesUnited StatesTime FactorsNeoplasmsProspective StudiesReproducibility of ResultsAntimalarialsDrug CombinationsSulfadoxinePyrimethamineDrug ResistanceMalaria, FalciparumDrug Therapy, CombinationAnti-Bacterial AgentsChloroquineRecurrenceArtemisininsAmodiaquineFollow-Up StudiesFluorenesProguanilKidney Failure, ChronicPlasmodium falciparumFailure to ThriveAtovaquoneDihydropteroate SynthaseSurvival AnalysisCefiximeDrug Resistance, ViralAnti-HIV AgentsPrognosisLiver Failure, AcuteDrug Administration ScheduleAntiprotozoal AgentsHIV InfectionsAntitubercular AgentsMicrobial Sensitivity TestsPenicillin G ProcaineParasitic Sensitivity TestsAmoxicillinAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesMetronidazoleSurvival RateDisease-Free SurvivalRisk FactorsLiver FailureDrug Resistance, BacterialGonorrheaMelarsoprolDrug MonitoringAzithromycinFluoxymesteroneViral LoadCombined Modality TherapyEthanolaminesKaplan-Meier EstimateMultiple Organ FailureParasitemiaPredictive Value of TestsAntiretroviral Therapy, Highly ActiveSalvage TherapyHodgkin DiseaseUgandaTrypanosoma brucei gambienseGenotypeCeftriaxoneDoxorubicinAnti-Infective AgentsDouble-Blind MethodMycoplasma genitaliumTetrahydrofolate DehydrogenaseAcute DiseaseVincristineAntimonyEquipment FailureCD4 Lymphocyte CountDisease ProgressionMutationCardiac Output, LowPharyngeal DiseasesPrednisoneSeverity of Illness IndexNeisseria gonorrhoeaeHeart Failure, SystolicAcute Kidney InjuryStaphylococcal InfectionsPatient ComplianceMefloquineVancomycinHIV-1Polymerase Chain ReactionAnti-Retroviral AgentsDrug Resistance, Neoplasm